Biotech · Private company
dsm-firmenich Switzerland AG
Track this companyFree. Adds dsm-firmenich Switzerland AG to your Dealase workspace and tells you when its record changes.
Clinical trials120 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Bemotrizinol (6%)Phase 3 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
- 6% Bemotrizinol (BEMT) dispersion in petrolatumPhase 2 · SunburnClinicalTrials.gov · fetched Nov 12, 2026
- 6% Bemotrizinol (BEMT) in a basic sunscreen oil formulationPhase 2 · SunburnClinicalTrials.gov · fetched Nov 12, 2026
- 6% Bemotrizinol in petrolatumPhase 2 · Photoallergic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- 6% Bemotrizinol in sunscreen formulationPhase 2 · Photoallergic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- Dispersion of 6% BEMT in petrolatumPhase 2 · Phototoxic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- Petrolatum vehiclePhase 2 · Phototoxic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- Petrolatum vehiclePhase 2 · SunburnClinicalTrials.gov · fetched Nov 12, 2026
- Sodium Lauryl Sulfate 0.1% (SLS)Phase 2 · SunburnClinicalTrials.gov · fetched Nov 12, 2026
- Sunscreen oil vehiclePhase 2 · Phototoxic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- Sunscreen oil vehicle with 10% ethanol as penetration enhancer without BEMTPhase 2 · SunburnClinicalTrials.gov · fetched Nov 12, 2026
- Sunscreen oil with 6% BemotrizinolPhase 2 · Phototoxic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 2 · Photoallergic ResponseClinicalTrials.gov · fetched Nov 12, 2026
- BemotrizinolPhase 1 · Absorption; ChemicalsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials12
- Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage TrialPHASE3 · COMPLETED · started Mar 15, 2022ClinicalTrials.gov NCT05277376 · fetched Nov 12, 2026
- Photoallergic Potential of 6% BemotrizinolPHASE2 · COMPLETED · started Mar 7, 2022ClinicalTrials.gov NCT05254912 · fetched Nov 12, 2026
- Phototoxicity Potential of 6% BemotrizinolPHASE2 · COMPLETED · started Feb 28, 2022ClinicalTrials.gov NCT05254925 · fetched Nov 12, 2026
- Dermal Irritation, Sensitization and Cumulative Irritation Potential of 6% BemotrizinolPHASE2 · COMPLETED · started Feb 23, 2022ClinicalTrials.gov NCT05260359 · fetched Nov 12, 2026
- Bemotrizinol UV Filter Part 1 Clinical PK Evaluation in Topical MUsT StudyPHASE1 · COMPLETED · started Nov 3, 2020ClinicalTrials.gov NCT04355286 · fetched Nov 12, 2026
- Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD)PHASE2 · COMPLETED · started Jan 3, 2020ClinicalTrials.gov NCT04198805 · fetched Nov 12, 2026
- Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer TreatmentPHASE2 · COMPLETED · started May 19, 2017ClinicalTrials.gov NCT01489813 · fetched Nov 12, 2026
- Effect of Dietary Supplementation on Dynamic StabilityNA · WITHDRAWN · started Sep 1, 2016ClinicalTrials.gov NCT02806765 · fetched Nov 12, 2026
- Docosahexaenoic Acid (DHA) To Prevent Development of Cognitive Dysfunction Due to ChemotherapyEARLY_PHASE1 · COMPLETED · started Jul 1, 2015ClinicalTrials.gov NCT02517502 · fetched Nov 12, 2026
- Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk WomenNA · COMPLETED · started Mar 1, 2014ClinicalTrials.gov NCT02101970 · fetched Nov 12, 2026
- Effect of Omega-3 Fatty Acid on Cortical Function in ADHDPHASE3 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01883817 · fetched Nov 12, 2026
- Antenatal Micronutrient Supplementation and Infant SurvivalPHASE3 · COMPLETED · started Jan 1, 2008ClinicalTrials.gov NCT00860470 · fetched Nov 12, 2026